Methylphenidate
Articles · Medicine Compliance Aid Stability · Lactation Safety Information · Published , updated
18548003
Articles
2nd May 2018
NICE Bites; Attention deficit hyperactivity disorder (ADHD)
Please go to NICE to check for any recent updates to this guideline. NICE Bites is a monthly prescribing bulletin published by North West Medicines… Adherence Atomoxetine Dexamfetamine Guanfacine Implementation Lisdexamfetamine Mental Health Mental health and illness Methylphenidate News Paediatric and neonatal medicine
27th April 2018
Extended-release methylphenidate – A review of the pharmacokinetic profiles of available preparations
This review provides a brief background to current NICE recommendations for the use of methylphenidate for the treatment of ADHD and summarises pertinent points with respect… Mental Health Mental health and illness Methylphenidate News Paediatric and neonatal medicine
3rd January 2018
Safety in Lactation: Drugs for ADHD
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. The use of drugs for attention… Atomoxetine Dexamfetamine Guanfacine Lisdexamfetamine Mental health and illness Methylphenidate Obstetrics and gynaecology Paediatric and neonatal medicine Safety in LactationMedicine Compliance Aid Stability
Medikinet XL · Flynn Pharma Ltd
Flynn Pharma Ltd
Medikinet XL
Capsules m/r 5mg, 10mg, 20mg, 30mg, 40mg
R2 · Red 2 · Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Protect from light. Protect from moisture.
1st February 2015
Ritalin · Novartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Ritalin
Tablets 10mg
A2 · Amber 2 · No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special requirements for storage.
1st February 2015
Medikinet · Flynn Pharma Ltd
Flynn Pharma Ltd
Medikinet
Tablets 5mg, 10mg, 20mg
R2 · Red 2 · Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Protect from light. Protect from moisture.
1st February 2015
Concerta XL · Janssen-Cilag Ltd
Janssen-Cilag Ltd
Concerta XL
Tablets m/r 18mg, 27mg, 36mg
R1 · Red 1 · Stability data indicates that the drug is not suitable for CAs.
Unsuitable
Not suitable for compliance aid - packaged with a desiccant.
1st February 2015
Equasym XL · Shire Pharmaceuticals Ltd
Shire Pharmaceuticals Ltd
Equasym XL
Capsules m/r 10mg, 20mg, 30mg
A2 · Amber 2 · No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special requirements for storage.
1st February 2015
Matoride XL · Sandoz Ltd
Sandoz Ltd
Matoride XL
Tablets prolonged release f/c 36mg, 54mg
R2 · Red 2 · Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Drying plug in bottle, protect from moisture.
30th October 2015
Lactation Safety Information
-
Limited published evidence of safety
Small amounts in breast milk
Monitor infant decreased appetite/weight gain, sleep disturbances, irritability
17th September 2018